Quest Diagnostics PE Ratio 2010-2025 | DGX

Current and historical p/e ratio for Quest Diagnostics (DGX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Quest Diagnostics PE ratio as of July 10, 2025 is 18.86.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Quest Diagnostics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-10 171.45 21.68
2025-03-31 167.61 $7.91 21.19
2024-12-31 148.72 $7.69 19.34
2024-09-30 152.29 $7.44 20.47
2024-06-30 133.56 $7.41 18.02
2024-03-31 129.14 $7.43 17.38
2023-12-31 133.06 $7.49 17.77
2023-09-30 116.92 $6.66 17.56
2023-06-30 134.17 $6.87 19.53
2023-03-31 134.38 $6.78 19.82
2022-12-31 147.93 $7.92 18.68
2022-09-30 115.39 $10.17 11.35
2022-06-30 124.47 $12.02 10.35
2022-03-31 126.86 $15.02 8.45
2021-12-31 159.67 $15.56 10.26
2021-09-30 133.53 $16.65 8.02
2021-06-30 120.70 $16.77 7.20
2021-03-31 116.83 $13.17 8.87
2020-12-31 107.99 $10.44 10.34
2020-09-30 103.24 $8.09 12.76
2020-06-30 102.27 $5.51 18.56
2020-03-31 71.52 $5.81 12.31
2019-12-31 94.64 $6.28 15.07
2019-09-30 94.37 $5.34 17.67
2019-06-30 89.31 $5.31 16.82
2019-03-31 78.42 $5.22 15.02
2018-12-31 72.17 $5.29 13.64
2018-09-30 93.08 $6.19 15.04
2018-06-30 94.41 $5.81 16.25
2018-03-31 85.69 $5.61 15.27
2017-12-31 83.76 $5.50 15.23
2017-09-30 79.26 $4.77 16.62
2017-06-30 93.70 $4.96 18.89
2017-03-31 82.39 $4.96 16.61
2016-12-31 76.74 $4.50 17.05
2016-09-30 70.67 $4.70 15.04
2016-06-30 67.32 $5.71 11.79
2016-03-31 58.76 $5.15 11.41
2015-12-31 58.18 $4.87 11.95
2015-09-30 49.96 $4.87 10.26
2015-06-30 58.63 $3.40 17.24
2015-03-31 61.82 $3.51 17.61
2014-12-31 53.69 $3.80 14.13
2014-09-30 48.31 $3.48 13.88
2014-06-30 46.47 $5.28 8.80
2014-03-31 45.61 $5.43 8.40
2013-12-31 41.92 $5.57 7.53
2013-09-30 48.38 $4.94 9.79
2013-06-30 47.25 $3.27 14.45
2013-03-31 43.78 $3.31 13.23
2012-12-31 44.71 $3.45 12.96
2012-09-30 48.67 $4.30 11.32
2012-06-30 45.84 $4.36 10.51
2012-03-31 46.66 $4.27 10.93
2011-12-31 44.05 $4.14 10.64
2011-09-30 37.37 $3.91 9.56
2011-06-30 44.74 $3.97 11.27
2011-03-31 43.55 $4.02 10.83
2010-12-31 40.65 $4.05 10.04
2010-09-30 38.01 $4.06 9.36
2010-06-30 37.33 $3.95 9.45
2010-03-31 43.65 $3.89 11.22
2009-12-31 45.14 $3.88 11.63
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.140B $9.872B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Encompass Health (EHC) United States $11.843B 25.10
DaVita (DVA) United States $10.831B 15.23
Elanco Animal Health (ELAN) United States $7.470B 16.00
Chemed (CHE) United States $6.813B 21.41
Option Care Health (OPCH) United States $4.993B 22.25
RadNet (RDNT) United States $4.314B 273.81
Amedisys (AMED) United States $3.205B 21.56
Addus HomeCare (ADUS) United States $2.064B 22.67
LifeStance Health (LFST) United States $1.839B 0.00
Astrana Health (ASTH) United States $1.436B 35.57
U.S Physical Therapy (USPH) United States $1.159B 29.91
Pennant (PNTG) United States $0.890B 32.67
Aveanna Healthcare Holdings (AVAH) United States $0.825B 47.00
Atai Life Sciences (ATAI) Germany $0.547B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.038B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00